<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">76622</article-id><article-id pub-id-type="doi">10.7554/eLife.76622</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Full spectrum flow cytometry reveals mesenchymal heterogeneity in first trimester placentae and phenotypic convergence in culture, providing insight into the origins of placental mesenchymal stromal cells</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-265143"><name><surname>Boss</surname><given-names>Anna Leabourn</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1943-4162</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-266416"><name><surname>Damani</surname><given-names>Tanvi</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283675"><name><surname>Wickman</surname><given-names>Tayla J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-214958"><name><surname>Chamley</surname><given-names>Larry W</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-266418"><name><surname>James</surname><given-names>Jo L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-266417"><name><surname>Brooks</surname><given-names>Anna ES</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3551-6982</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Obstetrics and Gynaecology</institution>, <institution>University of Auckland</institution>, <addr-line><named-content content-type="city">Auckland</named-content></addr-line>, <country>New Zealand</country></aff><aff id="aff2"><institution content-type="dept">School of Biological Sciences</institution>, <institution>University of Auckland</institution>, <addr-line><named-content content-type="city">Auckland</named-content></addr-line>, <country>New Zealand</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-50376"><name><surname>Joseph</surname><given-names>Fredrick Rosario</given-names></name><role>Reviewing editor</role><aff><institution>University of Colorado Anschutz Medical Campus</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>a.boss@auckland.ac.nz</email> (AB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>03</day><month>08</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e76622</elocation-id><history><date date-type="received"><day>23</day><month>12</month><year>2021</year></date><date date-type="accepted"><day>01</day><month>08</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Boss et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Boss et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-76622-v1.pdf"/><abstract><p>Single-cell technologies (RNA-sequencing, flow cytometry) are critical tools to reveal how cell heterogeneity impacts developmental pathways. The placenta is a fetal exchange organ, containing a heterogeneous mix of mesenchymal cells (fibroblasts, myofibroblasts, perivascular, and progenitor cells) . Placental mesenchymal stromal cells (pMSC) are also routinely isolated, for therapeutic and research purposes. However, our understanding of the diverse phenotypes of placental mesenchymal lineages, and their relationships remain unclear. We designed a 23-colour flow cytometry panel to assess mesenchymal heterogeneity in first-trimester human placentae. . Four distinct mesenchymal subsets were identified; CD73<sup>+</sup>CD90<sup>+</sup> mesenchymal cells, CD146<sup>+</sup>CD271<sup>+</sup> perivascular cells, podoplanin<sup>+</sup>CD36<sup>+</sup> stromal cells, and CD26<sup>+</sup>CD90<sup>+</sup> myofibroblasts. CD73<sup>+</sup>CD90<sup>+</sup> and podoplanin+CD36+ cells expressed markers consistent with cultured pMSCs, and were explored further. Despite their distinct ex-vivo phenotype, in culture CD73<sup>+</sup>CD90<sup>+</sup> cells and podoplanin<sup>+</sup>CD36<sup>+</sup> cells underwent phenotypic convergence, losing CD271 or CD36 expression respectively, and homogenously exhibiting a basic MSC phenotype (CD73<sup>+</sup>CD90<sup>+</sup>CD31<sup>-</sup>CD144<sup>-</sup>CD45<sup>-</sup>). However, some markers (CD26, CD146) were not impacted, or differentially impacted by culture in different populations. Comparisons of cultured phenotypes to pMSCs further suggested cultured pMSCs originate from podoplanin<sup>+</sup>CD36<sup>+ </sup>cells. This highlights the importance of detailed cell phenotyping to optimise therapeutic capacity, and ensure use of relevant cells in functional assays.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001505</institution-id><institution>Health Research Council of New Zealand</institution></institution-wrap></funding-source><award-id>16/043</award-id><principal-award-recipient><name><surname>James</surname><given-names>Jo L</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001537</institution-id><institution>University of Auckland</institution></institution-wrap></funding-source><award-id>Doctoral Scholarship</award-id><principal-award-recipient><name><surname>Boss</surname><given-names>Anna Leabourn</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Placentae were collected following informed consent with approval from the Northern X Health and Disability Ethics Committee (NTX/12/06/057/AM09).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>FCS data files have been provided for flow cytometry presented in Figures 2-3 following the link: http://flowrepository.org/public_experiment_representations/FR-FCM-Z4TJFigure 4:http://flowrepository.org/public_experiment_representations/FR-FCM-Z4TLFigure 7:http://flowrepository.org/public_experiment_representations/FR-FCM-Z5FV</p></sec><supplementary-material><ext-link xlink:href="elife-76622-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>